ARCHIVES

Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

December 31, 2010

No More Free Cancergrams, But NCI Will Save a Bundle

October 17, 1986

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008

Duke Researchers Retract Paper from Blood; Dozens of Retractions of Potti’s Work Expected

September 9, 2011

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998